Fibrosis–a common pathway to organ injury and failure
The DOI matches its Crossref record; 117 of the 118 references it cites were found in a registry or an index.
Abstract
Fibrosis is a consequence of the inflammatory response. When fibrotic tissue becomes excessive, it can have diverse pathophysiological effects on a number of organ systems. The mechanisms underlying fibrosis and approaches to therapy are reviewed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hepatocyte injury, apoptosis and necrosis promote a sterile inflammatory response. This includes activation of KCs to clear necrotic debris, recruitment of lymphocytes and bone-marrow-derived monocytes, extracellular matrix (ECM) remodelling, myofibroblast activation, angiogenesis, and hepatocyte regeneration and differentiation to replace lost hepatocytes.11,31,32”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [31]
In the citing paper
“Both receptors are independently involved in regulation of cell adhesion, differentiation, proliferation of myofibroblasts and migration of both myofibroblasts and macrophages.31”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [31]
Citations
Cites
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402582 · Cited by 3,975
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327
Massagué, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3434 · Cited by 3,128
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
Liaw, Y.-F., Sung, J. J. Y., Chow, W. C., Farrell, G., Lee, C.-Z., Yuen, H., Tanwandee, T., Tao, Q.-M., Shue, K., Keene, O. N., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033364 · Cited by 2,266
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,222
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Hinz, B., Phan, S. H., Thannickal, V. J., Galli, A., Bochaton-Piallat, M.-L., & Gabbiani, G. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070112 · Cited by 2,068
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
Research works printed but not linked: 1
- TORAFIC Investigators Group, 2011, Clin Ther, 33, 1204.e3
Cited by
Items 101–200 of 1,001
Heart failure: when form fails to follow function
Katz, A. M., & Rolett, E. L. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv548 · Cited by 141
“tually contributes to the development of fibrosis, arrhythmias, progressive myocardial deterioration, and end-stage heart failure.(54)”
BackgroundRole of Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease
Lovisa, S., Genovese, G., & Danese, S. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy201 · Cited by 154
Zamani, M. M., Alizadeh‐Tabari, S., Ajmera, V. H., Singh, S., Murad, M. H., & Loomba, R. S. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.08.020 · Cited by 171
Holvoet, T., Devriese, S., Castermans, K., Boland, S., Leysen, D. C., Vandewynckel, Y., Devisscher, L., den Bossche, L. V., Welden, S. V., Dullaers, M., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.06.013 · Cited by 141
Querfeld, U., MAK, R. H. K., & Pries, A. R. (2020) · Clinical Science · doi:10.1042/cs20200279 · Cited by 152
SOX9 switch links regeneration to fibrosis at the single-cell level in mammalian kidneys
Aggarwal, S., Wang, Z., Pacheco, D. R. F., Rinaldi, A., Rajewski, A. C., Callemeyn, J., Loon, E. V., Lamarthée, B., Covarrubias, A. E., Hou, J., et al. (2024) · Science · doi:10.1126/science.add6371 · Cited by 143
Sandner, P., & Stasch, J. P. (2016) · Respiratory Medicine · doi:10.1016/j.rmed.2016.08.022 · Cited by 145
Fibroblast Primary Cilia Are Required for Cardiac Fibrosis
Villalobos, E., Criollo, A., Schiattarella, G. G., Altamirano, F., French, K. M., May, H. I., Jiang, N., Nguyen, N. U. N., Romero, D., Roa, J. C., et al. (2019) · Circulation · doi:10.1161/circulationaha.117.028752 · Cited by 131
Self-citationAnalysis of Generalized Fibrosis in Mouse Tissue Sections with Masson’s Trichrome Staining
van de Vlekkert, D., Machado, E., & d’Azzo, A. (2020) · BIO-PROTOCOL · doi:10.21769/bioprotoc.3629 · Cited by 161
The cycling and aging mouse female reproductive tract at single-cell resolution
Winkler, I., Tolkachov, A., Lammers, F., Lacour, P., Daugėlaitė, K., Schneider, N. G., Koch, M.-L., Panten, J., Grünschläger, F., Poth, T., et al. (2024) · Cell · doi:10.1016/j.cell.2024.01.021 · Cited by 143
Hepatocyte TLR4 triggers inter-hepatocyte Jagged1/Notch signaling to determine NASH-induced fibrosis
Yu, J., Zhu, C., Wang, X., Kim, K., Bartolome, A., Dongiovanni, P., Yates, K. P., Valenti, L., Carrer, M., Sadowski, T., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abe1692 · Cited by 132
“A subset of these patients develops considerable hepatocellular injury, liver inflammation, and fibrosis, which define the transition from simple steatosis to nonalcoholic steatohepatitis (NASH) (3, 4).”
BackgroundMechanisms of kidney fibrosis and routes towards therapy
YAMASHITA, N., & Kramann, R. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.09.001 · Cited by 143
FOXO1/3: Potential suppressors of fibrosis
Xin, Z., Ma, Z., Hu, W., Jiang, S., Yang, Z. P., Li, T. X., Chen, F., Jia, G., & Yang, Y. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.11.002 · Cited by 144
Tang, P. M., Zhou, S., Li, C., Liao, J., Xiao, J., Wang, Q., Lian, G., Li, J., Huang, X., To, K., et al. (2017) · Kidney International · doi:10.1016/j.kint.2017.07.026 · Cited by 134
Mechanisms for the Resolution of Organ Fibrosis
Horowitz, J. C., & Thannickal, V. J. (2018) · Physiology · doi:10.1152/physiol.00033.2018 · Cited by 144
Haarhaus, M. L., Cianciolo, G., Barbuto, S., Manna, G. L., Gasperoni, L., Tripepi, G. L., Plebani, M., Fusaro, M., & Magnusson, P. (2022) · Nutrients · doi:10.3390/nu14102124 · Cited by 146
HDAC inhibitors as antifibrotic drugs in cardiac and pulmonary fibrosis
Lyu, X., Hu, M., Peng, J., Zhang, X., & Sanders, Y. Y. (2019) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622319862697 · Cited by 130
Molecular imaging of fibrosis: recent advances and future directions
Montesi, S. B., Désogère, P., Fuchs, B. C., & Caravan, P. (2019) · Journal of Clinical Investigation · doi:10.1172/jci122132 · Cited by 127
Han, J., Bae, J., Choi, C.-Y., Choi, S.-P., Kang, H.-S., Jo, E.-K., Park, J., Lee, Y. S., Moon, H.-S., Park, C.-G., et al. (2016) · Autophagy · doi:10.1080/15548627.2016.1235124 · Cited by 126
Liu, Y., Aron-Wisnewsky, J., Marcelin, G., Genser, L., Le Naour, G., Torcivia, A., Bauvois, B., Bouchet, S., Pelloux, V., Sasso, M., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3348 · Cited by 126
Richter, H., Satz, A. L., Bedoucha, M., Buettelmann, B., Petersen, A. C., Harmeier, A., Hermosilla, R., Hochstrasser, R., Burger, D., Gsell, B., et al. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00866 · Cited by 124
JMJD3 in the regulation of human diseases
Zhang, X., Liu, L., Yuan, X., Wei, Y., & Wei, X. (2019) · Protein & Cell · doi:10.1007/s13238-019-0653-9 · Cited by 120
Mechanisms of Regeneration and Fibrosis in the Endometrium
Ang, C. J., Skokan, T. D., & McKinley, K. L. (2023) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-011723-021442 · Cited by 139
Zhu, Y., Tan, J., Xie, H., Wang, J., Meng, X., & Wang, R. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12769 · Cited by 130
Current advances on the therapeutic potential of pinocembrin: An updated review
Elbatreek, M. H., Mahdi, I., Ouchari, W., Mahmoud, M. F., & Sobeh, M. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114032 · Cited by 132
AMPK in cardiac fibrosis and repair: Actions beyond metabolic regulation
Daskalopoulos, E. P., Dufeys, C., Bertrand, L., Beauloye, C., & Horman, S. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.01.001 · Cited by 126
A review of pharmacological and pharmacokinetic properties of stachydrine
Cheng, F., Zhou, Y., Wang, M., Guo, C., Cao, Z., Zhang, R., & Peng, C. Y. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104755 · Cited by 127
Zhou, Y., Men, L., Sun, Y., Wei, M., & Fan, X. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173796 · Cited by 125
Widespread Translational Control of Fibrosis in the Human Heart by RNA-Binding Proteins
Chothani, S. P., Schäfer, S., Adami, E., Viswanathan, S., Widjaja, A. A., Langley, S. R., Tan, J., Wang, M., Quaife, N. M., Pua, C. J., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.039596 · Cited by 143
Role of cellular senescence in inflammation and regeneration
Saito, Y., Yamamoto, S., & Chikenji, T. (2024) · Inflammation and Regeneration · doi:10.1186/s41232-024-00342-5 · Cited by 140
Understanding the cellular interactome of non-alcoholic fatty liver disease
Wallace, S. J., Tacke, F., Schwabe, R. F., & Henderson, N. C. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100524 · Cited by 116
New Insights into Hippo/YAP Signaling in Fibrotic Diseases
Mia, M. M., & Singh, M. K. (2022) · Cells · doi:10.3390/cells11132065 · Cited by 116
Osteopontin—A Master Regulator of Epithelial-Mesenchymal Transition
Kothari, A., Arffa, M., Chang, V., Blackwell, R., Syn, W.-K., Zhang, J., Mi, Z., & Kuo, P. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5040039 · Cited by 115
NUAK1 promotes organ fibrosis via YAP and TGF-β/SMAD signaling
Zhang, T., He, X., Caldwell, L., Goru, S. K., Severino, L. U., Tolosa, M. F., Misra, P. S., McEvoy, C. M., Christova, T. Y., Liu, Y., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz4028 · Cited by 124
Chanzyme TRPM7 protects against cardiovascular inflammation and fibrosis
Rios, F. J. O., Zou, Z., Harvey, A., Harvey, K. Y., Nosalski, R., Anyfanti, P., Camargo, L. L., Lacchini, S., Ryazanov, A. G., Ryazanova, L. V., et al. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz164 · Cited by 119
Multiple organ dysfunction syndrome: Contemporary insights on the clinicopathological spectrum
Asim, M., Amin, F., & El-Menyar, A. A. (2020) · Qatar medical journal · doi:10.5339/qmj.2020.1 · Cited by 126
Mechanism of fibrosis and stricture formation in Crohn's disease
Alfredsson, J., & Wick, M. J. (2020) · Scandinavian Journal of Immunology · doi:10.1111/sji.12990 · Cited by 124
Melatonin: the dawning of a treatment for fibrosis?
Hu, W., Ma, Z., Jiang, S., Fan, C., Deng, C., Yan, X., Di, S., Lv, J., Reiter, R. J., & Yang, Y. (2016) · Journal of Pineal Research · doi:10.1111/jpi.12302 · Cited by 115
Jasso, G. J., Jaiswal, A., Varma, M., Laszewski, T., Grauel, A. L., Omar, A. S., Silva, N., Dranoff, G., Porter, J. A., Mansfield, K. G., et al. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001532 · Cited by 122
Tampe, B., Steinle, U., Tampe, D., Carstens, J. L., Korsten, P., Zeisberg, E. M., Muller, G. A., Kalluri, R., & Zeisberg, M. (2016) · Kidney International · doi:10.1016/j.kint.2016.07.042 · Cited by 116
Therapeutic effects of serum extracellular vesicles in liver fibrosis
Chen, L., Chen, R., Kemper, S., Cong, M., You, H., & Brigstock, D. R. (2018) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2018.1461505 · Cited by 120
Wu, J., Subbaiah, K. C. V., Xie, L. H., Jiang, F., Khor, E.-S., Mickelsen, D. M., Myers, J. R., Tang, W. H. W., & Yao, P. (2020) · Circulation Research · doi:10.1161/circresaha.119.315999 · Cited by 120
Long, M. T., Zhang, X., Xu, H., Liu, C., Corey, K. E., Chung, R. T., Loomba, R., & Benjamin, E. J. (2021) · Hepatology · doi:10.1002/hep.31608 · Cited by 110
Engineered 3D cardiac fibrotic tissue to study fibrotic remodeling
Sadeghi, A. H., Shin, S. R., Deddens, J. C., Fratta, G., Mandla, S., Yazdi, I. K., Prakash, G., Antona, S., Demarchi, D., Buijsrogge, M. P., et al. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201601434 · Cited by 108
“8,10,18 An important cause of the limited development of improved and more specific therapies against cardiac fibrosis is the lack of biomimetic in vitro platforms to investigate the fibrogenic remodeling after cardiac injury.”
RIPK3 promotes kidney fibrosis via AKT-dependent ATP citrate lyase
Imamura, M., Moon, J., Chung, K., Nakahira, K., Muthukumar, T., Shingarev, R. A., Ryter, S. W., Choi, A. M. K., & Choi, M. E. (2018) · JCI Insight · doi:10.1172/jci.insight.94979 · Cited by 114
Yang, E. Y., Ghosn, M. G., Khan, M. A., Gramze, N. L., Brunner, G., Nabi, F., Nambi, V., Nagueh, S. F., Nguyen, D. T., Graviss, E. A., et al. (2019) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.119.009535 · Cited by 107
Myofibroblast YAP/TAZ activation is a key step in organ fibrogenesis
He, X., Tolosa, M. F., Zhang, T., Goru, S. K., Ulloa Severino, L., Misra, P. S., McEvoy, C. M., Caldwell, L., Szeto, S. G., Gao, F., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.146243 · Cited by 106
Aspirin use is associated with lower indices of liver fibrosis among adults in the United States
Jiang, Z. G., Feldbrügge, L., Tapper, E. B., Popov, Y., Ghaziani, T., Afdhal, N., Robson, S. C., & Mukamal, K. J. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13515 · Cited by 107
Tang, W., Zhao, Z., Chong, Y., Wu, C., Liu, Q., Yang, J., Zhou, R., Lian, Z., & Liang, G. (2018) · ACS Nano · doi:10.1021/acsnano.8b04143 · Cited by 107
Advances in the study of emodin: an update on pharmacological properties and mechanistic basis
Zheng, Q., Li, S., Li, X., & Liu, R. (2021) · Chinese Medicine · doi:10.1186/s13020-021-00509-z · Cited by 117
Cell–scaffold interactions in tissue engineering for oral and craniofacial reconstruction
Wang, F., Cai, X., Shen, Y., & Meng, L. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.10.029 · Cited by 133
αv integrins on mesenchymal cells regulate skeletal and cardiac muscle fibrosis
Murray, I. R., Gonzalez, Z. N., Baily, J., Dobie, R., Wallace, R. J., Mackinnon, A. C., Smith, J. R., Greenhalgh, S. N., Thompson, A. I., Conroy, K. P., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01097-z · Cited by 106
Fisher, G. J., Wang, B., Cui, Y., Shi, M., Zhao, Y., Quan, T., & Voorhees, J. J. (2023) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-023-00743-0 · Cited by 113
Skeletal and cardiac muscle pericytes: Functions and therapeutic potential
Murray, I. R., Baily, J. E., Chen, W. C. W., Dar, A., Gonzalez-Galofre, Z. N., Jensen, A. R., Petrigliano, F. A., Deb, A., & Henderson, N. C. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.09.005 · Cited by 117
Exosomes derived from hucMSC attenuate renal fibrosis through CK1δ/β-TRCP-mediated YAP degradation
Ji, C., Zhang, J., Zhu, Y. X., Shi, H., Yin, S., Sun, F., Wang, Q., Zhang, L., Yan, Y., Zhang, X., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2510-4 · Cited by 110
Spontaneous Chitin Accumulation in Airways and Age-Related Fibrotic Lung Disease
Van Dyken, S. J., Liang, H.-E., Naikawadi, R. P., Woodruff, P. G., Wolters, P. J., Erle, D. J., & Locksley, R. M. (2017) · Cell · doi:10.1016/j.cell.2017.03.044 · Cited by 104
Li, X., Zhu, L., Wang, B., Yuan, M., & Zhu, R. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00855 · Cited by 108
Cardiorenal syndrome: Multi‐organ dysfunction involving the heart, kidney and vasculature
Savira, F., Magaye, R., Liew, D., Reid, C. M., Kelly, D. J., Kompa, A. R., Sangaralingham, S. J., Burnett, J. C. J., Kaye, D. M., & Wang, B. H. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15065 · Cited by 137
Liu, L., Sun, Q., Davis, F., Mao, J., Zhao, H., & Ma, D. (2022) · Burns & Trauma · doi:10.1093/burnst/tkac011 · Cited by 98
Luo, X.-Y., Meng, X.-J., Cao, D.-C., Wang, W., Zhou, K., Li, L., Guo, M., & Wang, P. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1122-8 · Cited by 99
Idiopathic subglottic stenosis is associated with activation of the inflammatory IL‐17A/IL‐23 axis
Gelbard, A. H., Katsantonis, N., Mizuta, M., Newcomb, D. C., Rotsinger, J. E., Rousseau, B., Daniero, J. J., Edell, E. S., Ekbom, D. C., Kasperbauer, J. L., et al. (2016) · The Laryngoscope · doi:10.1002/lary.26098 · Cited by 102
Yang, S., Wang, M., Wang, T., Sun, M., Huang, H., Shi, X., Duan, S., Wu, Y., Zhu, J., & Liu, F. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100644 · Cited by 114
Liu, L., Yu, H., Zhao, H., Wu, Z., Long, Y., Zhang, J., Yan, X., You, Z., Zhou, L., Xia, T., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1910650117 · Cited by 94
Meissner, E. G., McLaughlin, M., Matthews, L., Gharib, A. M., Wood, B. J., Levy, E., Sinkus, R., Virtaneva, K., Sturdevant, D., Martens, C., et al. (2016) · Liver International · doi:10.1111/liv.13177 · Cited by 94
LARP6 Meets Collagen mRNA: Specific Regulation of Type I Collagen Expression
Zhang, Y., & Stefanovic, B. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030419 · Cited by 97
Hao, K., Lei, W., Wu, H., Wu, J., Yang, Z., Yan, S., Lu, X., Li, J., Xia, X., Han, X., et al. (2019) · Theranostics · doi:10.7150/thno.33920 · Cited by 95
Fibrosis development in early-onset muscular dystrophies: Mechanisms and translational implications
Serrano, A. L., & Muñoz-Cánoves, P. (2017) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2016.09.013 · Cited by 94
Collagen Fibrils Mechanically Contribute to Tissue Contraction in an In Vitro Wound Healing Scenario
Brauer, E., Lippens, E., Klein, O., Nebrich, G., Schreivogel, S., Korus, G., Duda, G. N., & Petersen, A. (2019) · Advanced Science · doi:10.1002/advs.201801780 · Cited by 102
Cao, Y., Mai, W., Li, R., Deng, S., Li, L., Zhou, Y., Qin, Q., Zhang, Y., Zhou, X., Han, M., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04319-w · Cited by 97
Post-myocardial infarction fibrosis: Pathophysiology, examination, and intervention
Yin, X., Yin, X., Pan, X., Zhang, J., Fan, X., Li, J., Zhai, X., Jiang, L., Hao, P., Wang, J., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1070973 · Cited by 111
Exosomes and exosomal miRNAs from muscle-derived fibroblasts promote skeletal muscle fibrosis
Zanotti, S., Gibertini, S., Blàsevich, F., Bragato, C., Ruggieri, A., Saredi, S., Fabbri, M., Bernasconi, P., Maggi, L., Mantegazza, R., et al. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.07.003 · Cited by 101
Endothelium-mediated contributions to fibrosis
Sun, X., Nkennor, B., Mastikhina, O., Soon, K., & Nunes, S. S. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.10.015 · Cited by 100
Dysregulated mesenchymal PDGFR‐β drives kidney fibrosis
Buhl, E. M., Djudjaj, S., Klinkhammer, B. M., Ermert, K., Puelles, V. G., Lindenmeyer, M. T., Cohen, C. D., He, C., Borkham‐Kamphorst, E., Weiskirchen, R., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201911021 · Cited by 95
Michael, S., Ni, J., Duncan, E. S., Liu, Z., Li, S., Zhang, J., Guo, R., Gao, S., Gao, X., & Fan, G. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105481 · Cited by 95
A Staphylococcus pro-apoptotic peptide induces acute exacerbation of pulmonary fibrosis
D’Alessandro‐Gabazza, C. N., Kobayashi, T., Yasuma, T., Toda, M., Kim, H., Fujimoto, H., Hataji, O., Takeshita, A., Nishihama, K., Okano, T., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15344-3 · Cited by 98
CXCL4 drives fibrosis by promoting several key cellular and molecular processes
Affandi, A. J., Carvalheiro, T., Ottria, A., de Haan, J. J., Brans, M. A. D., Brandt, M. M., Tieland, R. G., Lopes, A. P., Malvar‐Fernández, B., Bekker, C. P. J., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110189 · Cited by 93
Relationships among injury, fibrosis, and time in human kidney transplants
Venner, J. M., Famulski, K. S., REEVE, J. P., Chang, J. J., & Halloran, P. F. (2016) · JCI Insight · doi:10.1172/jci.insight.85323 · Cited by 93
Ahamed, J., & Laurence, J. C. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7064 · Cited by 88
Zeybel, M., Luli, S., Sabater, L., Hardy, T., Oakley, F., Leslie, J., Page, A., Moran Salvador, E., Sharkey, V., Tsukamoto, H., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2016.10.004 · Cited by 84
Targeting Fibrosis: From Molecular Mechanisms to Advanced Therapies
Di, X., Li, Y., Wei, J., Li, T., & Liao, B. (2024) · Advanced Science · doi:10.1002/advs.202410416 · Cited by 124
Dong, J., Dong, Y., Chen, Z., Mitch, W. E., & Zhang, L. (2017) · Kidney International · doi:10.1016/j.kint.2016.07.029 · Cited by 81
Exosomes in immunoregulation of chronic lung diseases
Hough, K. P., Chanda, D., Duncan, S. R., Thannickal, V. J., & Deshane, J. S. (2016) · Allergy · doi:10.1111/all.13086 · Cited by 88
IL‐11 in cardiac and renal fibrosis: Late to the party but a central player
Corden, B., Adami, E., Sweeney, M., Schafer, S., & Cook, S. A. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15013 · Cited by 85
Kidney Clearance of Secretory Solutes Is Associated with Progression of CKD: The CRIC Study
Chen, Y., Zelnick, L. R., Wang, K., Hoofnagle, A. N., Becker, J. O., Hsu, C., Feldman, H. I., Mehta, R. C., Lash, J. P., Waikar, S. S., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019080811 · Cited by 95
Fighting the Fiber: Targeting Collagen in Lung Fibrosis
Staab-Weijnitz, C. A. (2022) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2021-0342tr · Cited by 91
Chronic Kidney Disease and Fibrosis: The Role of Uremic Retention Solutes
Mutsaers, H. A. M., Stribos, E. G. D., Glorieux, G., Vanholder, R. C., & Olinga, P. (2015) · Frontiers in Medicine · doi:10.3389/fmed.2015.00060 · Cited by 92
Prommer, H.-U., Maurer, J., von Websky, K., Freise, C., Sommer, K., Nasser, H., Samapati, R., Reglin, B., Guimarães, P., Pries, A. R., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-23663-1 · Cited by 85
Collagen cross-linking mediated by lysyl hydroxylase 2: an enzymatic battlefield to combat fibrosis
Piersma, B., & Bank, R. A. (2019) · Essays in Biochemistry · doi:10.1042/ebc20180051 · Cited by 84
Luo, Z., Sun, Y., Qi, B., Lin, J., Chen, Y., Xu, Y., & Chen, J. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.01.016 · Cited by 98
Multiple Fibroblast Subtypes Contribute to Matrix Deposition in Pulmonary Fibrosis
Liu, X., Dai, K., Zhang, X., Huang, G., Lynn, H., Rabata, A., Liang, J., Noble, P. W., & Jiang, D. (2023) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2022-0292oc · Cited by 96
Fibroblast activation and heterogeneity in fibrotic disease
Zhang, X., Zhang, Y., & Liu, Y. (2025) · Nature Reviews Nephrology · doi:10.1038/s41581-025-00969-8 · Cited by 101
Genetic tools for identifying and manipulating fibroblasts in the mouse
Swonger, J. M., Liu, J. S., Ivey, M. J., & Tallquist, M. D. (2016) · Differentiation · doi:10.1016/j.diff.2016.05.009 · Cited by 84
Hermida, N., Michel, L. Y. M., Esfahani, H., Dubois‐Deruy, E., Hammond, J., Bouzin, C., Markl, A., Colin, H., Steenbergen, A. V., de Meester, C., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx366 · Cited by 81
Maloney, J. P., & Gao, L. (2015) · Mediators of Inflammation · doi:10.1155/2015/387842 · Cited by 80
Villanueva, C., Graupera, I., Aracil, C., Alvarado‐Tápias, E., Miñana, J. M., Puente, Á., Hernández–Gea, V., Ardèvol, A., Pavel, O., Colomo, A., et al. (2017) · Hepatology · doi:10.1002/hep.29056 · Cited by 89
Jorgenson, A. J., Choi, K. M., Sicard, D., Smith, K. M. J., Hiemer, S. E., Varelas, X., & Tschumperlin, D. J. (2017) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00205.2016 · Cited by 78
Cardinali, D. P., Brown, G. M., Reiter, R. J., & Pandi-Perumal, S. R. (2020) · Sleep and Vigilance · doi:10.1007/s41782-020-00111-7 · Cited by 78
Notch-mediated hepatocyte MCP-1 secretion causes liver fibrosis
Kang, J., Postigo-Fernandez, J., Kim, K., Zhu, C., Yu, J., Meroni, M., Mayfield, B., Bartolomé, A., Dapito, D. H., Ferrante, A. W., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.165369 · Cited by 78
Lavall, D., Jacobs, N., Mahfoud, F., Kolkhof, P., Böhm, M., & Laufs, U. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.07.001 · Cited by 82
Alveolar cells under mechanical stressed niche: critical contributors to pulmonary fibrosis
Yang, J., Pan, X., Wang, L., & Yu, G. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00223-w · Cited by 90
Metadata
- Authors
- Rockey, D. C., Bell, P. D., & Hill, J. A.
- Affiliations
- Medical University of South Carolina (US)
- The University of Texas Southwestern Medical Center (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-03-19
- Volume
- 372
- Issue
- 12
- Pages
- 1138-1149
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1977437151
- Cited by
- 1,428
- References
- 118
- Citations by year
- 2026: 104 · 2025: 116 · 2024: 154 · 2023: 149 · 2022: 162 · 2021: 162 · 2020: 152 · 2019: 118 · 2018: 96 · 2017: 94 · 2016: 85 · 2015: 33
- FWCI
- 14.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- fibrosis, organ damage, organ failure, inflammation, fibrosis mechanisms, fibrosis treatment
- MeSH terms
- Fibrosis, Humans, Multiple Organ Failure, Transforming Growth Factor beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.